Recent market projections reveal a promising future for the Global Empty Capsules Industry, setting the stage for substantial growth and market expansion. According to industry reports, sales in the Global Empty Capsules sector are expected to reach an impressive US$ 2.3 Billion in 2023, with a highly optimistic outlook for the years ahead.

The market’s upward trajectory is further emphasized by a projected Compound Annual Growth Rate (CAGR) of 7.9% between 2023 and 2033. This consistent growth is anticipated to culminate in a remarkable valuation of US$ 4.9 Billion by 2033, signifying the industry’s resilience and potential to meet the evolving demands of the global market.

Request a Sample Copy of This Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-782

Driving Factors Behind Surging Demand for Empty Capsules:

The primary drivers behind the surging demand for empty capsules are twofold. First, there is a noticeable uptick in the popularity of capsules as the preferred form of drug delivery. This shift is further accentuated by the increasing consumption of various medications. Secondly, as the global burden of chronic diseases continues to escalate, the demand for effective therapeutics is expected to surge, presenting lucrative opportunities for suppliers of empty capsules.

The Advantages of Capsule-Based Drug Delivery Systems:

Moreover, the shift towards capsule-based drug delivery systems can be attributed to their several advantages, including improved bioavailability, better patient compliance, and enhanced efficacy. These benefits have significantly contributed to the growing preference for capsules among both patients and healthcare professionals. As a result, the demand for empty capsules is on a continuous rise.

A Promising Future for the Global Empty Capsules Industry:

In summary, the future of the Global Empty Capsules Industry appears incredibly promising, with robust growth prospects anticipated in the years ahead. Key industry players operating in the market are well-positioned to benefit from this trend, provided they adapt to evolving consumer preferences and invest in product innovation to maintain a competitive edge.

Empty capsules are known as protective shells for drugs designed from special film-forming materials such as gelatin, starch, and pullulan. Being innovative drug delivery products, they are utilized by leading pharmaceutical and biopharmaceutical companies due to their various attractive features. Such capsules are economical, oxidation resistant, offer maximum flexibility, and are easy to use on account of their smooth and slippery nature. Furthermore, they are especially suitable for substances having a bitter taste and unpleasant odor.

Key Takeaways:

  • With a market share of more than 38.3%, North America now dominates the global empty capsules industry.
  • Western Europe and Eastern Europe currently have market shares of more than 18.8% and 7.8%, respectively.
  • Latin America is expected to develop significantly throughout the projected period, accounting for more than 9.7% of the Global Empty Capsules Industry.
  • The German empty capsules market is committed to the region’s growth. The German market is expected to reach US$ 269.6 million by 2033, growing at a CAGR of 7.9% in the interim.
  • Gelatin-based capsules, particularly 00 gelatin capsules, 000 gelatin capsules, size 5 gelatin capsules, and size 3 gelatin capsules, are expected to grow in popularity until 2033.
  • In recent years, there has been a significant growth in the consumption of nutraceuticals to strengthen immunity and compensate for the nutrition lost owing to poor eating habits and the irregularity of a sedentary lifestyle.

Competitive Landscape

The Global Empty Capsules Industry is known to be highly competitive in nature attributed to the presence of leading empty pill manufacturers that account for over 70% of the global market share. Prominent market players are constantly focusing on introducing new products designed out of innovative materials. In addition to that, they are adopting growth strategies such as partnerships, mergers, acquisitions, etc. to expand their global footprint.

List encompassing key players operating in the Global Empty Capsules Industry

  • ACG Worldwide
  • Capsugel
  • Qualicaps Inc.
  • Bright Pharma Caps Inc.
  • Sunil Healthcare Ltd.
  • CapsCanada Corporation
  • Roxlor LLC
  • Snail Pharma Industry Co. Ltd.
  • Suheung Co. Ltd.
  • Medi-Caps Ltd

Key Segments of Empty Capsules Industry Survey

Capsule Size:

  • Size “000” Empty Capsules
  • Size “00” Empty Capsules
  • Size “0” Empty Capsules
  • Size “1” Empty Capsules
  • Size “2” Empty Capsules
  • Size “3” Empty Capsules
  • Size “4” Empty Capsules
  • Size “5” Empty Capsules

Product Type:

  • Gelatin (Hard)-based Capsules
  • Vegetarian-based Capsules

Route of Administration:

  • Empty Capsules for Oral Administration
  • Empty Capsules for Inhalation

Raw Material:

  • Contract Type-A (Pork Skin) Empty Capsules
  • Type-B Gelatin (Animal Bones & Calf Skin) Empty Capsules
  • Fish Bone Gelatin Empty Capsules
  • Empty Hydroxy Propyl Methyl Cellulose (HPMC) Empty Capsules
  • Starch Material Empty Capsules
  • Empty Pullulan Capsules

End User:

  • Empty Capsules for Pharmaceutical Companies
  • Empty Capsules for Cosmetic & Nutraceutical Companies
  • Empty Capsules for Clinical Research Organizations (CROS)